Skip to main content

Daniel M. Skovronsky, M.D., Ph.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when Illumina, Inc. publishes a filing, an earnings call transcript or a press release.

Get ILMN alerts

About Daniel M. Skovronsky, M.D., Ph.D.

Daniel M. Skovronsky, M.D., Ph.D. is recorded as Board Member at Illumina, Inc. (ILMN) since June 16, 2026. Illumina, Inc. reported in an 8-K filed June 23, 2026 that Daniel M. Skovronsky, M.D., Ph.D. was appointed Board of Directors, effective June 16, 2026. Illumina, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Illumina, Inc. includes Jay T. Flatley (Chairman), John W. Thompson (Chairman), Scott Gottlieb (Chairman and Board Member) and 7 others.

“On June 16, 2026, the Board of Directors (the "Board") of Illumina, Inc. (the "Company") increased the size of the Board from nine to ten members and appointed Daniel M. Skovronsky, M.D., Ph.D., to serve on the Board, effective immediately.”
Illumina, Inc. Form 8-K, filed June 23, 2026 · Read the filing

Affiliation history

Company network

Current role

Diagnostics & Research · Healthcare

Board Member

2026-06-16–present

Leadership on record at Illumina, Inc.

Recent activity